1
|
Su Y, Chen Y, Zhang W, Liu L, Cao X, Wu J. Platelet factor 4 and β-thromboglobulin mRNAs in circulating microparticles of trauma patients as diagnostic markers for deep vein thrombosis. J Thromb Thrombolysis 2020; 50:525-32. [PMID: 32347511 DOI: 10.1007/s11239-020-02124-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Deep vein thrombosis (DVT) is a common complication after trauma. The development of markers to predict DVT in trauma patients is needed, and circulating microparticles (MPs) and their contents are possible candidates. In this study, we aimed to identify platelet factor 4 (PF4) and β-thromboglobulin (β-TG) mRNAs in circulating MPs as potential markers for DVT diagnosis in trauma patients. Fifteen trauma patients diagnosed with DVT and fifteen matched patients without DVT were included in this study. Fifteen healthy volunteers also were included as controls. Circulating MPs were obtained from the plasma of all study subjects. Annexin V+ MPs and platelet-derived MPs (PMPs) were quantified using flow cytometry. PF4 and β-TG mRNAs in MPs were determined by qPCR, and the common logarithm of relative quantitation (RQ) was calculated using the comparative Ct method. Receiver-operating characteristic (ROC) curves were performed to analyze the diagnostic value of PF4 and β-TG mRNAs. No significant differences were found in Annexin V+ MPs and PMPs levels between trauma patients with and without DVT. However, both PF4 and β-TG mRNAs in MPs from the DVT group were significantly higher than the non-DVT group and healthy controls (P = 0.014 for PF4, P = 0.010 for β-TG). The ROC curve analysis showed that both the PF4 mRNA (area-under curve (AUC) 0.756, P = 0.017) and the β-TG mRNA (AUC 0.751, P = 0.019) had a positive predictive value for DVT. This finding indicates that the PF4 and β-TG mRNAs in MPs may be used as potential biomarkers for DVT diagnosis in trauma patients.
Collapse
|
2
|
Chansai S, Fucharoen S, Fucharoen G, Jetsrisuparb A, Chumpia W. Elevations of Thrombotic Biomarkers in Hemoglobin H Disease. Acta Haematol 2018; 139:47-51. [PMID: 29402840 DOI: 10.1159/000486157] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2017] [Accepted: 12/07/2017] [Indexed: 11/19/2022]
Abstract
BACKGROUND Thalassemia is a group of hereditary hemoglobinopathies caused by decreased or absent synthesis of α and/or β globin chains. Studies have shown that hypercoagulability and thrombosis are common clinical symptoms in β-thalassemia, especially β-thalassemia intermedia, but little is known about in α-thalassemia. This study aims to examine phosphatidylserine (PS) levels, platelet activation, and coagulation markers in splenectomized (S) and nonsplenectomy (NS) patients with hemoglobin (Hb) H disease. METHODS The NS group comprised 20 patients (median age 15.0 years, range, 14-16.5 years), and the S group consisted of 11 patients (median age 16.4 years, range, 14-19.9 years) with Hb H disease; the control group consisted of 20 normal subjects. Hematological parameters were collected. Flow cytometry was used to measure PS exposure on red blood cells. The levels of intercellular adhesive molecule (ICAM)-1, tumor necrosis factor α (TNFα), β-thromboglobulin (TG) and prothrombin fragment 1 + 2 (F1.2) were determined using ELISA test kits. RESULTS Significant increases in the levels of PS, ICAM-1, TNFα, β-TG, and F1.2 were observed in both patient groups compared to normal controls (p < 0.01). CONCLUSION This observation indicates blood coagulation, endothelial injury, chronic low-grade inflammation, platelet activation, and thrombin generation are present in Hb H disease; these findings merit further assessment in a larger prospective cohort to establish possible links with thrombotic manifestations.
Collapse
Affiliation(s)
- Siriyakorn Chansai
- Medical Science Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand
| | - Supan Fucharoen
- Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand
| | - Goonnapa Fucharoen
- Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand
| | - Arunee Jetsrisuparb
- Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
| | - Worawan Chumpia
- Division of Medical Technology, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand
| |
Collapse
|
3
|
Wang YQ, Wang B, Liang Y, Cao SH, Liu L, Xu XN. Role of platelet TLR4 expression in pathogensis of septic thrombocytopenia. World J Emerg Med 2014; 2:13-7. [PMID: 25214976 DOI: 10.5847/wjem.j.1920-8642.2011.01.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2010] [Accepted: 12/15/2010] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND Infection-induced thrombocytopenia (TCP) is an independent risk factor for death of patients with sepsis, but its mechanism is unknown. This study aimed to explore the underlying mechanism of TCP based on the relationship between TLR4 expression and platelet activation in septic patients. METHODS A total of 64 patients with sepsis were prospectively studied. Platelet count (PC), mean platelet volume (MPV), platelet distribution width (PDW), platelet TLR4 expression, platelet PAC-1 expression, sCD40L and TNF-α concentrations were compared between the healthy control group (15 volunteers) and sepsis group (64 patients) at admission and on the 3, 5, and 9 days after admission. The changes of MPV and PDW in the TCP and non-TCP subgroups of sepsis before and after treatment were recorded. Prognostic index was analyzed. RESULTS PC was lower in the sepsis group (P=0.006), and MPV and PDW were higher in the sepsis group than those in the healthy control group (P=0.046, P=0.001). Platelet TLR4 and PAC-1 expressions, and sCD40L and TNF-α levels increased more significantly in the sepsis group (P<0.001). PAC-1 expression and TNF-α level were higher in the TCP group than in the non-TCP group before and after treatment (P=0.023, P=0.011). sCD40L concentration and platelet TLR4 expression were significantly higher in the treated TCP group than in the non-TCP group (P=0.047, P=0.001). Compared to the non-TCP group, the rate of bleeding was higher (P=0.024) and the length of ICU stay was longer (P=0.013). The APACHE II score and the 28-day mortality were higher in the TCP group (P<0.01, P=0.048). CONCLUSIONS The elevation of platelet TLR4 expression in sepsis along with platelet activation is closely related to the incidence of thrombocytopenia. The occurrence of TCP is a sign of poor prognosis in sepsis patients.
Collapse
Affiliation(s)
- Yong-Qiang Wang
- ICU, Tianjin First Center Hospitial, Tianjin 300192, China (WangYQ, Wang B, Cao SH, Xu XN); Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China (Liang Y); General Hospital of Tianjin Medical University, Tianjin 300052, China (Liu L)
| | - Bing Wang
- ICU, Tianjin First Center Hospitial, Tianjin 300192, China (WangYQ, Wang B, Cao SH, Xu XN); Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China (Liang Y); General Hospital of Tianjin Medical University, Tianjin 300052, China (Liu L)
| | - Yong Liang
- ICU, Tianjin First Center Hospitial, Tianjin 300192, China (WangYQ, Wang B, Cao SH, Xu XN); Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China (Liang Y); General Hospital of Tianjin Medical University, Tianjin 300052, China (Liu L)
| | - Shu-Hua Cao
- ICU, Tianjin First Center Hospitial, Tianjin 300192, China (WangYQ, Wang B, Cao SH, Xu XN); Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China (Liang Y); General Hospital of Tianjin Medical University, Tianjin 300052, China (Liu L)
| | - Li Liu
- ICU, Tianjin First Center Hospitial, Tianjin 300192, China (WangYQ, Wang B, Cao SH, Xu XN); Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China (Liang Y); General Hospital of Tianjin Medical University, Tianjin 300052, China (Liu L)
| | - Xin-Nv Xu
- ICU, Tianjin First Center Hospitial, Tianjin 300192, China (WangYQ, Wang B, Cao SH, Xu XN); Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China (Liang Y); General Hospital of Tianjin Medical University, Tianjin 300052, China (Liu L)
| |
Collapse
|